Improving Radiation Treatment for Cancer
Radiation Biology
This program works to make radiation therapy more effective for cancer patients, aiming to better control tumors and help people live longer, healthier lives.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11099819 on NIH RePORTER |
What this research studies
Our program focuses on enhancing radiation therapy for cancer patients by finding new ways to combine treatments that improve tumor control while protecting healthy tissues. We are also developing advanced technologies for planning and delivering radiation, along with new markers to understand how patients respond to treatment, predict outcomes, and identify potential side effects. This work uses a variety of methods, from basic science discoveries and preclinical models to advanced genomics, imaging, engineering, and artificial intelligence, all with the goal of moving promising approaches into clinical trials for patients.
Who could benefit from this research
Good fit: Patients with various types of cancer who are undergoing or considering radiation therapy may ultimately benefit from the advancements made through this program.
Not a fit: Patients whose cancer is not typically treated with radiation therapy or those who do not have cancer may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to more effective radiation treatments with fewer side effects, improving both tumor control and survival for cancer patients.
How similar studies have performed: Radiation therapy is a well-established cancer treatment, and ongoing research continually refines its effectiveness and safety, building on past successes.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Le, Quynh-Thu Xuan — Stanford University
- Study coordinator: Le, Quynh-Thu Xuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.